Gemmer Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$705K Sell
5,485
-23
-0.4% -$2.69K 0.05% 96
2026
Q1
$663K Buy
5,508
+793
+17% +$91.6K 0.05% 96
2025
Q4
$496K Buy
4,715
+71
+2% +$6.67K 0.04% 109
2025
Q3
$390K Sell
4,644
-367
-7% -$30.2K 0.03% 118
2025
Q2
$397K Buy
5,011
+395
+9% +$31.4K 0.04% 113
2025
Q1
$414K Buy
4,616
+676
+17% +$63.1K 0.04% 105
2024
Q4
$392K Buy
3,940
+849
+27% +$87.5K 0.04% 106
2024
Q3
$351K Sell
3,091
-350
-10% -$41.6K 0.04% 107
2024
Q2
$426K Sell
3,441
-126
-4% -$16.2K 0.05% 93
2024
Q1
$471K Buy
3,567
+454
+15% +$56K 0.05% 84
2023
Q4
$339K Buy
3,113
+35
+1% +$3.63K 0.04% 94
2023
Q3
$317K Sell
3,078
-205
-6% -$22.1K 0.04% 93
2023
Q2
$379K Buy
3,283
+206
+7% +$23.4K 0.05% 83
2023
Q1
$327K Sell
3,077
-851
-22% -$91.9K 0.05% 95
2022
Q4
$436K Sell
3,928
-85
-2% -$8.69K 0.07% 75
2022
Q3
$346K Buy
4,013
+300
+8% +$26.8K 0.06% 89
2022
Q2
$339K Hold
3,713
0.05% 87
2022
Q1
$304K Hold
3,713
0.04% 102
2021
Q4
$285K Buy
3,713
+20
+0.5% +$1.59K 0.03% 102
2021
Q3
$277K Buy
3,693
+3
+0.1% +$228 0.04% 98
2021
Q2
$287K Sell
3,690
-134
-4% -$9.97K 0.04% 103
2021
Q1
$281K Buy
3,824
+106
+3% +$7.82K 0.04% 98
2020
Q4
$290K Hold
3,718
0.05% 82
2020
Q3
$294K Buy
3,718
+1
+0% +$78 0.05% 75
2020
Q2
$274K Buy
3,717
+17
+0.5% +$1.28K 0.06% 78
2020
Q1
$272K Sell
3,700
-283
-7% -$22.2K 0.07% 71
2019
Q4
$346K Hold
3,983
0.08% 68
2019
Q3
$320K Sell
3,983
-108
-3% -$8.66K 0.08% 74
2019
Q2
$327K Buy
4,091
+754
+23% +$57.7K 0.09% 69
2019
Q1
$265K Buy
3,337
+380
+13% +$28.4K 0.07% 76
2018
Q4
$216K Sell
2,957
-14,077
-83% -$994K 0.07% 79
2018
Q3
$1.15M Buy
17,034
+1,114
+7% +$71K 0.36% 38
2018
Q2
$922K Sell
15,920
-8,896
-36% -$502K 0.32% 43
2018
Q1
$1.29M Buy
24,816
+2,979
+14% +$161K 0.44% 39
2017
Q4
$1.17M Buy
21,837
+3,736
+21% +$207K 0.41% 41
2017
Q3
$1.11M Buy
18,101
+4,485
+33% +$272K 0.42% 41
2017
Q2
$833K Buy
13,616
+6,436
+90% +$392K 0.35% 45
2017
Q1
$435K Buy
7,180
+2,921
+69% +$177K 0.19% 55
2016
Q4
$239K Buy
4,259
+1,030
+32% +$60.3K 0.12% 63
2016
Q3
$192K Buy
3,229
+495
+18% +$28.9K 0.1% 68
2016
Q2
$150K Sell
2,734
-454
-14% -$24.2K 0.08% 76
2016
Q1
$160K Buy
3,188
+291
+10% +$14.3K 0.09% 79
2015
Q4
$146K Buy
2,897
+195
+7% +$9.83K 0.09% 82
2015
Q3
$127K Sell
2,702
-35
-1% -$1.86K 0.08% 95
2015
Q2
$149K Buy
2,737
+34
+1% +$1.91K 0.09% 85
2015
Q1
$148K Sell
2,703
-12
-0.4% -$679 0.09% 86
2014
Q4
$147K Buy
2,715
+1
+0% +$56 0.1% 83
2014
Q3
$154K Hold
2,714
0.11% 81
2014
Q2
$150K Hold
2,714
0.1% 80
2014
Q1
$147K Buy
+2,714
New +$141K 0.1% 82

Other funds holding MRK

Gemmer Asset Management's MRK Position: Q2 2026 in Review

Gemmer Asset Management reduced its Merck (MRK) stake by 0.42% in Q2 2026, selling an estimated $2.69K and leaving 5,485 shares worth $705K. The position accounts for 0.05% of the portfolio, ranked #96.

Gemmer Asset Management first reported a position in MRK in Q1 2014 and has held it in 50 quarters since. The position peaked at $1.29M in Q1 2018. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Gemmer Asset Management held 5,485 shares of Merck worth $705K as of Q2 2026.
  • Gemmer Asset Management sold 23 Merck shares in Q2 2026, an estimated $2.69K.
  • Merck made up 0.05% of Gemmer Asset Management's portfolio in Q2 2026, its #96 holding.
  • Gemmer Asset Management first reported a position in Merck in Q1 2014 and has held it in 50 quarters since.
  • Gemmer Asset Management's Merck position peaked at $1.29M in Q1 2018.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Gemmer Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.